 |
 |
 |
 |
 |
 |
 |
 |
Tenofovir (Viread)
Overview
- A Clinical Overview of Tenofovir (Viread) (April 2, 2010)
From AIDSinfo - Prescribing Information for Tenofovir (Viread) (PDF) (October 2009)
From Gilead Sciences, Inc. - Drug Interactions: Tenofovir (August 2004)
[Archived Article]
From Project Inform - Gilead's Viread International Access Program (May 2003)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis - Tenofovir DF 300 mg Consistently Demonstrates Anti-HIV Activity Regardless of Baseline Demographic Characteristics in Antiretroviral Experienced HIV-1-Infected Patients (October 29, 2001)
[Archived Article]
In 8th European Conference on Clinical Aspects and Treatment of HIV-Infection, from The Body PRO
News
- Expanded Indication for Viread, to Include the Treatment of Patients 12 to Less Than 18 Years of Age (March 24, 2010)
From U.S. Food and Drug Administration - FDA Approves Gilead's Antiretroviral Viread for Use as Hepatitis B Treatment (August 13, 2008)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Good Step for Generics (January 25, 2008)
Looser patent laws could mean generic version of Tenofovir to come.
In Housing Works AIDS Issues Update, from Housing Works - U.S. Patent Agency to Review Gilead's Claim on Tenofovir (July 20, 2007)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Gilead Lowers Its No-Profit Drug Prices for Truvada, Viread (August 30, 2005)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Viread (Tenofovir Disoproxil Fumarate) Labeling Revision (May 13, 2005)
[Archived Article]
Among the revisions is updated information regarding drug resistance and long-term effects on bone mineral density.
From U.S. Food and Drug Administration - Two New Fixed-Dose Combinations Approved (August 2, 2004)
From U.S. Food and Drug Administration - Food and Drug Administration to Expedite Decision on Emtricitabine/Tenofovir Pill (May 18, 2004)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Drug Development News: Fixed-Dose Combinations (May/June 2004)
The Food and Drug Administration's fast-track approval process for fixed-dose combinations is about to bear fruit.
In GMHC Treatment Issues, from Gay Men's Health Crisis - Revised Labeling for Viread (Tenofovir Disoproxil Fumarate) 300 mg Tablets (November 4, 2003)
[Archived Article]
From U.S. Food and Drug Administration - Gilead Warns Against Use of Triple-NRTI Regimen 3TC, ddI, Tenofovir (October 14, 2003)
[Archived Article]
To read PDF, click here.
From U.S. Food and Drug Administration - Atazanavir/Tenofovir Combo Should Be Boosted With Ritonavir (August 8, 2003)
[Archived Article]
From U.S. Food and Drug Administration - FDA Orders Gilead for Second Time to Stop Downplaying Risks, Inflating Benefits of Antiretroviral Drug Viread (August 8, 2003)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - European Union Gives Thumbs-Up to Tenofovir Use in Treatment-Naive Patients (May 28, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Three French Cases of Tenofovir Kidney Toxicity Reported Amongst HIV-Positive Patients (April 8, 2003)
[Archived Article]
From aidsmap.com - HIV-Positive Man Dies of Kidney Failure and Lactic Acidosis Due to Tenofovir/ddI Interaction (April 8, 2003)
[Archived Article]
From aidsmap.com - Gilead Offers Tenofovir to Developing Countries at Cost (April 4, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - New Safety Information -- Viread Co-Administration With Videx (September 30, 2002)
[Archived Article]
From U.S. Food and Drug Administration - ddI-Tenofovir Interaction Warning (PDF) (May 7, 2002)
[Archived Article]
From Bristol-Myers Squibb Company - More Uses for Tenofovir? (January 25, 2002)
[Archived Article]
The drug's usefulness in pregnant women, as a microbicide or as first-line therapy has yet to be thoroughly investigated.
To read PDF, click here.
In AIDS Treatment News, from AIDS Treatment News - Nutrient Deficiency Associated With New HIV Medication (December 2001)
[Archived Article]
In Survival News, from AIDS Survival Project - Tenofovir (Viread), First Novel Antiviral Agent in Six Years, Approved by FDA (November 2001)
[Archived Article]
In TAGline, from Treatment Action Group - FDA Approves Viread for HIV-1 Infection (October 29, 2001)
[Archived Article]
From U.S. Food and Drug Administration
Clinical Management
Clinical Management
  |
The Body PRO is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body PRO and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body PRO's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body PRO is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body PRO should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.